S
XBI icon

SignatureFD’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SignatureFD’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
1,034
+1
+0.1% +$135 ﹤0.01% 1190
2026
Q1 		$132K Buy
1,033
+8
+0.8% +$999 ﹤0.01% 1221
2025
Q4 		$125K Sell
1,025
-660
-39% -$75.7K ﹤0.01% 1208
2025
Q3 		$169K Hold
1,685
– – ﹤0.01% 1033
2025
Q2 		$140K Sell
1,685
-100
-6% -$7.98K ﹤0.01% 1075
2025
Q1 		$145K Sell
1,785
-549
-24% -$49.1K ﹤0.01% 1033
2024
Q4 		$210K Buy
2,334
+598
+34% +$57.9K ﹤0.01% 855
2024
Q3 		$171K Buy
1,736
+12
+0.7% +$1.18K ﹤0.01% 949
2024
Q2 		$160K Buy
1,724
+1
+0.1% +$90 ﹤0.01% 922
2024
Q1 		$164K Hold
1,723
– – ﹤0.01% 924
2023
Q4 		$154K Sell
1,723
-425
-20% -$31.6K ﹤0.01% 909
2023
Q3 		$157K Buy
2,148
+1,024
+91% +$81.8K ﹤0.01% 834
2023
Q2 		$93.5K Buy
1,124
+4
+0.4% +$335 ﹤0.01% 1095
2023
Q1 		$85.4K Hold
1,120
– – ﹤0.01% 1123
2022
Q4 		$93K Hold
1,120
– – ﹤0.01% 1044
2022
Q3 		$89K Buy
1,120
+20
+2% +$1.69K ﹤0.01% 1017
2022
Q2 		$82K Buy
1,100
+941
+592% +$70.6K ﹤0.01% 1070
2022
Q1 		$14K Sell
159
-154
-49% -$14.2K ﹤0.01% 2021
2021
Q4 		$35K Hold
313
– – ﹤0.01% 1516
2021
Q3 		$39K Sell
313
-2
-0.6% -$258 ﹤0.01% 1446
2021
Q2 		$43K Buy
315
+215
+215% +$28.3K ﹤0.01% 1352
2021
Q1 		$14K Hold
100
– – ﹤0.01% 1722
2020
Q4 		$14K Buy
+100
New +$12.8K ﹤0.01% 1587

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

SignatureFD's XBI Position: Q2 2026 in Review

SignatureFD increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.1% in Q2 2026, buying an estimated $135 and bringing the position to 1,034 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

SignatureFD first reported a position in XBI in Q4 2020 and has held it in 23 quarters since. The position peaked at $210K in Q4 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • SignatureFD held 1,034 shares of State Street SPDR S&P Biotech ETF worth $164K as of Q2 2026.
  • SignatureFD bought 1 State Street SPDR S&P Biotech ETF share in Q2 2026, an estimated $135.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1190 holding.
  • SignatureFD first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 23 quarters since.
  • SignatureFD's State Street SPDR S&P Biotech ETF position peaked at $210K in Q4 2024.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.